DE60213441D1 - Verwendung des aminoglycosidresistenzgens - Google Patents

Verwendung des aminoglycosidresistenzgens

Info

Publication number
DE60213441D1
DE60213441D1 DE60213441T DE60213441T DE60213441D1 DE 60213441 D1 DE60213441 D1 DE 60213441D1 DE 60213441 T DE60213441 T DE 60213441T DE 60213441 T DE60213441 T DE 60213441T DE 60213441 D1 DE60213441 D1 DE 60213441D1
Authority
DE
Germany
Prior art keywords
aminoglycosidresistence
gene product
resistance gene
animal cells
achieving high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60213441T
Other languages
English (en)
Other versions
DE60213441T2 (de
Inventor
Mohamed Al-Rubeai
Angelo Perani
Andy Racher
John Birch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AL RUBEAI MOHAMED
Lonza Biologics PLC
Original Assignee
AL RUBEAI MOHAMED
Lonza Biologics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AL RUBEAI MOHAMED, Lonza Biologics PLC filed Critical AL RUBEAI MOHAMED
Publication of DE60213441D1 publication Critical patent/DE60213441D1/de
Application granted granted Critical
Publication of DE60213441T2 publication Critical patent/DE60213441T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/38—Vector systems having a special element relevant for transcription being a stuffer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DE60213441T 2001-09-26 2002-09-26 Verwendung des aminoglycosidresistenzgens Expired - Lifetime DE60213441T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0123098.6A GB0123098D0 (en) 2001-09-26 2001-09-26 Use of aminoglycoside resistance gene
GB0123098 2001-09-26
US38759502P 2002-06-16 2002-06-16
PCT/GB2002/004522 WO2003027300A2 (en) 2001-09-26 2002-09-26 Use of aminoglycoside resistance gene

Publications (2)

Publication Number Publication Date
DE60213441D1 true DE60213441D1 (de) 2006-09-07
DE60213441T2 DE60213441T2 (de) 2007-12-13

Family

ID=26246578

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60213441T Expired - Lifetime DE60213441T2 (de) 2001-09-26 2002-09-26 Verwendung des aminoglycosidresistenzgens

Country Status (13)

Country Link
US (1) US7439037B2 (de)
EP (1) EP1438411B1 (de)
JP (1) JP4267450B2 (de)
KR (1) KR100982153B1 (de)
CN (1) CN100402653C (de)
AT (1) ATE334215T1 (de)
AU (1) AU2002334102A1 (de)
DE (1) DE60213441T2 (de)
DK (1) DK1438411T3 (de)
ES (1) ES2269807T3 (de)
GB (1) GB0123098D0 (de)
NO (1) NO332092B1 (de)
WO (1) WO2003027300A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2343362T4 (da) * 2006-07-14 2024-07-08 Patheon Holdings I B V Forbedret fremgangsmåde til dyrkning af celler
WO2016176275A1 (en) * 2015-04-27 2016-11-03 Momenta Pharmaceuticals, Inc. Methods of manufacturing therapeutic proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024947A (en) 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5077214A (en) * 1989-07-07 1991-12-31 The Texas A&M University System Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
WO1994026087A2 (en) * 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
FR2708284B1 (fr) * 1993-07-26 1995-10-20 Agronomique Inst Nat Rech Séquences nucléotidiques permettant la réplication et le maintien d'une information génétique dans les cellules animales.
GB2289946B (en) 1994-05-26 1998-09-23 Food Industry Res & Dev Inst Method
KR20010069066A (ko) * 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법

Also Published As

Publication number Publication date
WO2003027300A2 (en) 2003-04-03
EP1438411A2 (de) 2004-07-21
KR20040054698A (ko) 2004-06-25
CN100402653C (zh) 2008-07-16
CN1705749A (zh) 2005-12-07
US7439037B2 (en) 2008-10-21
US20050112722A1 (en) 2005-05-26
JP2005518189A (ja) 2005-06-23
NO20041856L (no) 2004-06-22
JP4267450B2 (ja) 2009-05-27
WO2003027300A3 (en) 2003-08-21
ATE334215T1 (de) 2006-08-15
AU2002334102A1 (en) 2003-04-07
KR100982153B1 (ko) 2010-09-14
EP1438411B1 (de) 2006-07-26
NO20041856D0 (no) 2004-04-23
ES2269807T3 (es) 2007-04-01
DE60213441T2 (de) 2007-12-13
NO332092B1 (no) 2012-06-18
GB0123098D0 (en) 2001-11-14
DK1438411T3 (da) 2006-11-20

Similar Documents

Publication Publication Date Title
SI1520008T1 (sl) Mediji brez Ĺľivalskih proteinov za kultiviranje celic
HK1120522A1 (en) Cell growth inhibitors containing anti-glypican 3 antibody
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
ATE454463T1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
IS7638A (is) Asabísýkló-oktan- og nónanafleiður með DDP-IV tálmunarvirkni
GEP20084341B (en) Aminoheteroaryl compounds as protein kinase inhibitors
MX336500B (es) Insecticida para uso agricola u horticola y metodo para su uso.
DK1766012T3 (da) Antisense-antibakteriel fremgangsmåde og forbindelse
DE69913712D1 (de) Inhibitoren der bakteriellen nad synthetase
ATE288922T1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
MXPA02002838A (es) Derivados de piperazina sustituidos, su obtencion y uso como medicamentos.
DE60213441D1 (de) Verwendung des aminoglycosidresistenzgens
AU2003223634A1 (en) Peptide deformylase inhibitors
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
EP1476149A4 (de) Substituierte hydrazone als hemmer von cyclooxygenase-2
ATE370964T1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
AU2002258437A1 (en) Peptide deformylase inhibitors
AU2003304490A1 (en) Peptide deformylase inhibitors
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
IS7441A (is) Peptíðdeformýlasatálmar
FR2801900B1 (fr) Methode de production de cellules animales adherentes
AU2002322035A1 (en) Peptide deformylase inhibitors
DE60232650D1 (de) Peptiddeformylaseinhibitoren
SI2287288T1 (sl) Mediji brez Ĺľivalskih proteinov za kultiviranje celic
AU2002255635A1 (en) Peptide deformylase inhibitors

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition